Redcare Pharmacy NV (XSWX:RDC) Marketable Securities: CHF39 Mil (As of Mar. 2026)


XSWX:RDC Redcare Pharmacy NV XSWX:RDC
48 GF Score
Price CHF60.95
GF Value CHF143.20
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Redcare Pharmacy NV Marketable Securities?

Redcare Pharmacy NV XSWX:RDC 48 Marketable Securities is CHF39 Mil as of Mar. 2026. GuruFocus rates XSWX:RDC with a GF Score™ of 48/100 and a GF Value™ of CHF143.20 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Redcare Pharmacy NV's Marketable Securities for the quarter that ended in Mar. 2026 was CHF39 Mil.

Redcare Pharmacy NV's annual Marketable Securities declined from Dec. 2023 (CHF113 Mil) to Dec. 2024 (CHF75 Mil) but then increased from Dec. 2024 (CHF75 Mil) to Dec. 2025 (CHF104 Mil).

Redcare Pharmacy NV  (XSWX:RDC) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Redcare Pharmacy NV Marketable Securities Related Terms

Redcare Pharmacy NV Marketable Securities Historical Data

* Premium members only.

The historical data trend for Redcare Pharmacy NV's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Redcare Pharmacy NV Marketable Securities Chart

Redcare Pharmacy NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 37.90 111.83 113.17 75.34 103.67

Redcare Pharmacy NV Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 77.18 207.21 112.98 103.67 38.59
XSWX:RDC
48GF Score
Redcare Pharmacy NV XSWX:RDC
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Redcare Pharmacy NV Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of CHF39 Mil mean?
Redcare Pharmacy NV (XSWX:RDC) has a Marketable Securities of CHF39 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Redcare Pharmacy NV and its competitors.
Is Redcare Pharmacy NV's Marketable Securities too high?
Redcare Pharmacy NV's current Marketable Securities is CHF39 Mil. Overall, Redcare Pharmacy NV has a GF Score™ of 48/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Redcare Pharmacy NV's Marketable Securities compare to competitors?
Redcare Pharmacy NV's Marketable Securities of CHF39 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Redcare Pharmacy NV and its competitors. Redcare Pharmacy NV's current Marketable Securities is CHF39 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Redcare Pharmacy NV stock overvalued right now?
Based on GuruFocus' analysis, Redcare Pharmacy NV (XSWX:RDC) is currently considered Significantly Undervalued. The stock's GF Value™ is CHF143.20, compared to a current price of CHF60.95 — trading 57.4% below its estimated fair value. The current Marketable Securities is CHF39 Mil. Redcare Pharmacy NV's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Redcare Pharmacy NV (XSWX:RDC), the current Marketable Securities is CHF39 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Redcare Pharmacy NV (XSWX:RDC) Overvalued in 2026?

Based on GuruFocus' analysis, Redcare Pharmacy NV stock appears to be undervalued. The current stock price of CHF60.95 is trading 57.4% below its estimated GF Value™ of CHF143.20. GuruFocus considers Redcare Pharmacy NV to be Significantly Undervalued.

Key valuation signals for XSWX:RDC:

  • Marketable Securities: CHF39 Mil
  • GF Value™: CHF143.20 vs. price of CHF60.95 (57.4% below fair value)
  • GF Score™: 48/100 with 2 warning signs

No single metric tells the full story. See the XSWX:RDC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Redcare Pharmacy NV Business Description

Address Erik de Rodeweg 11/13, Sevenum, ZH, NLD, 5975 WD
Redcare Pharmacy NV is an online pharmacy business for prescription and nonprescription (over-the-counter) pharmaceuticals, beauty and personal care products (BPC) and food supplements. Besides OTC, nutritional supplements, beauty and personal care products as well as an extensive assortment of health-related products in all markets, the company also provides prescription drugs for customers in Germany, Switzerland and the Netherlands. It operates in two segments, namely DACH segment that includes sales in Germany, Austria and Switzerland; and the International segment that includes sales across Belgium, the Netherlands, France and Italy. The DACH segment accounts for the majority of the revenue.
48GF Score

Get the complete analysis for XSWX:RDC

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF60.95
Price
CHF143.20
GF Value